Cart
sales@molnova.com
Home - Products - MAPK/ERK Signaling - ERK - XMD17-109

XMD17-109

CAS No. 1435488-37-1

XMD17-109 ( ERK5-IN-1 )

Catalog No. M11852 CAS No. 1435488-37-1

XMD17-109 is a novel, specific ERK-5 inhibitor with an EC50 4.2 uM in HEK293 cells.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 43 In Stock
5MG 71 In Stock
10MG 132 In Stock
25MG 210 In Stock
50MG 339 In Stock
100MG 510 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    XMD17-109
  • Note
    Research use only, not for human use.
  • Brief Description
    XMD17-109 is a novel, specific ERK-5 inhibitor with an EC50 4.2 uM in HEK293 cells.
  • Description
    XMD17-109 is a novel, specific ERK-5 inhibitor with an EC50 4.2 uM in HEK293 cells.
  • Synonyms
    ERK5-IN-1
  • Pathway
    MAPK/ERK Signaling
  • Target
    ERK
  • Recptor
    ERK5
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1435488-37-1
  • Formula Weight
    638.81
  • Molecular Formula
    C36H46N8O3
  • Purity
    >98%(HPLC)
  • Solubility
    Ethanol: 100 mg/mL (156.54 mM); DMSO: 100 mg/mL (156.54 mM)
  • SMILES
    CN1CCN(C2CCN(C(C3=CC(OCC)=C(NC4=NC=C5C(N(C6CCCC6)C(C=CC=C7)=C7C(N5C)=O)=N4)C=C3)=O)CC2)CC1
  • Chemical Name
    11-cyclopentyl-2-((2-ethoxy-4-(4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl)phenyl)amino)-5-methyl-5,11-dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Denq X, et al. Eur J Med Chem. 2013, 70, 758-767.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Muramyl dipeptide

    Muramyl dipeptide is a synthetic immunoreactive peptide, consisting of N-acetyl muramic acid attached to a short amino acid chain of L-Ala-D-isoGln.

  • Officinalisinin I

    Officinalisinin I can effectively reduce the blood glucose and protect nerve injuryin diabetic mice.

  • MK-8353

    MK-8353 (SCH-900353) is ahighly potent, orally bioavailable, dual-specificity ERK1/2 inhibitor with IC50 of 23.0/8.8 nM, respectively.

Sign In Join Free